| Performance of Galactomannan, Beta-d-Glucan, Aspergillus Lateral-Flow Device, Conventional Culture, and PCR Tests with Bronchoalveolar Lavage Fluid for … M Hoenigl, J Prattes, B Spiess, J Wagner, F Prueller, RB Raggam, ... Journal of clinical microbiology 52 (6), 2039-2045, 2014 | 263 | 2014 |
| The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin M Hoenigl, R Sprute, M Egger, A Arastehfar, OA Cornely, R Krause, ... Drugs 81, 1703-1729, 2021 | 218 | 2021 |
| Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the … M Hoenigl, J Salmanton-García, TJ Walsh, M Nucci, CF Neoh, JD Jenks, ... The Lancet Infectious Diseases 21 (8), e246-e257, 2021 | 216 | 2021 |
| Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of … J Prattes, J Wauters, DR Giacobbe, J Salmanton-García, J Maertens, ... Clinical Microbiology and Infection 28 (4), 580-587, 2022 | 170 | 2022 |
| Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases J Prattes, H Flick, F Prüller, C Koidl, RB Raggam, M Palfner, S Eigl, ... American journal of respiratory and critical care medicine 190 (8), 922-929, 2014 | 151 | 2014 |
| Invasive pulmonary aspergillosis complicating COVID-19 in the ICU-A case report J Prattes, T Valentin, M Hoenigl, E Talakic, AC Reisinger, P Eller Medical mycology case reports 31, 2-5, 2021 | 123 | 2021 |
| Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy JD Jenks, HJF Salzer, J Prattes, R Krause, D Buchheidt, M Hoenigl Drug design, development and therapy, 1033-1044, 2018 | 111 | 2018 |
| Autopsy Proven Pulmonary Mucormycosis Due to Rhizopus microsporus in a Critically Ill COVID-19 Patient with Underlying Hematological Malignancy C Zurl, M Hoenigl, E Schulz, S Hatzl, G Gorkiewicz, R Krause, P Eller, ... Journal of Fungi 7 (2), 88, 2021 | 108 | 2021 |
| Multicenter clinical experience of real life Dalbavancin use in gram-positive infections S Wunsch, R Krause, T Valentin, J Prattes, O Janata, A Lenger, ... International Journal of Infectious Diseases 81, 210-214, 2019 | 108 | 2019 |
| Diagnosis of invasive aspergillosis in hematological malignancy patients: performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage … S Heldt, J Prattes, S Eigl, B Spiess, H Flick, J Rabensteiner, G Johnson, ... Journal of Infection 77 (3), 235-241, 2018 | 100 | 2018 |
| Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis S Eigl, M Hoenigl, B Spiess, S Heldt, J Prattes, P Neumeister, A Wolfler, ... Medical mycology 55 (5), 528-534, 2017 | 98 | 2017 |
| Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test S Eigl, J Prattes, M Reinwald, CR Thornton, F Reischies, B Spiess, ... International journal of antimicrobial agents 46 (4), 401-405, 2015 | 93 | 2015 |
| Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients S Eigl, J Prattes, M Lackner, B Willinger, B Spiess, M Reinwald, B Selitsch, ... Critical care 19, 1-10, 2015 | 82 | 2015 |
| Clinical evaluation of the newly formatted lateral‐flow device for invasive pulmonary aspergillosis M Hoenigl, S Eigl, S Heldt, W Duettmann, C Thornton, J Prattes Mycoses 61 (1), 40-43, 2018 | 75 | 2018 |
| Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study S Hatzl, AC Reisinger, F Posch, J Prattes, M Stradner, S Pilz, P Eller, ... Critical Care 25, 1-11, 2021 | 74 | 2021 |
| Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis in solid organ transplant patients: a semiprospective multicenter study B Willinger, M Lackner, C Lass-Flörl, J Prattes, V Posch, B Selitsch, ... Transplantation 98 (8), 898-902, 2014 | 73 | 2014 |
| Diagnostic accuracy of the Aspergillus‐specific bronchoalveolar lavage lateral‐flow assay in haematological malignancy patients J Prattes, M Lackner, S Eigl, F Reischies, RB Raggam, C Koidl, H Flick, ... Mycoses 58 (8), 461-469, 2015 | 70 | 2015 |
| Characteristics of hospital-acquired and community-onset blood stream infections, South-East Austria M Hoenigl, J Wagner, RB Raggam, F Prueller, J Prattes, S Eigl, E Leitner, ... PloS one 9 (8), e104702, 2014 | 70 | 2014 |
| Characterisation of Candida within the Mycobiome/Microbiome of the Lower Respiratory Tract of ICU Patients R Krause, B Halwachs, GG Thallinger, I Klymiuk, G Gorkiewicz, M Hoenigl, ... PloS one 11 (5), e0155033, 2016 | 67 | 2016 |
| Mycobiome in the lower respiratory tract–a clinical perspective R Krause, C Moissl-Eichinger, B Halwachs, G Gorkiewicz, G Berg, ... Frontiers in Microbiology 7, 2169, 2017 | 54 | 2017 |
Martin HoeniglAssociate Professor of Translational Mycology, Medical University of Graz, AustriaVerified email at medunigraz.at
